药理学
药品
受体
胰高血糖素样肽-1
化学
医学
内分泌学
生物化学
糖尿病
2型糖尿病
作者
Naina Mohamed Pakkir Maideen
出处
期刊:Journal of analytical & pharmaceutical research
[MedCrave Group]
日期:2019-01-01
卷期号:8 (2): 51-53
被引量:7
标识
DOI:10.15406/japlr.2019.08.00311
摘要
Glucagon-like peptide-1 receptor agonists are incretin mimetics and they help to manage the blood glucose of patients with type 2 diabetes mellitus.The gastric emptying is delayed by the administration of Glucagon-like peptide-1 receptor agonists and hence the absorption of orally administered medications such as Acetaminophen, Digoxin, Warfarin, Oral contraceptive pills, Metformin, Statins, Angiotensin Converting Enzyme Inhibitors and Griseofulvin delayed by their concomitant use.It has been observed that the pharmacokinetics of all these drugs did not get altered by the concurrent administration of Glucagon-like peptide-1 receptor agonists.Moreover, the delay in absorption of interacting drugs could be avoided by taking 1 hour before the administration of Glucagon-like peptide-1 receptor agonists.
科研通智能强力驱动
Strongly Powered by AbleSci AI